Advertisement

Difficult Cases and Complications from Catheterization Laboratory: MitraClip Therapy in a Patient with Lack of Leaflet Coaptation

  • Marianna Adamo
  • Claudia Fiorina
  • Salvatore Curello
  • Ermanna Chiari
  • Giuliano Chizzola
  • Elena Pezzotti
  • Rosa Mastropierro
  • Federica EttoriEmail author
Chapter

Abstract

In patients with functional mitral regurgitation (MR) due to extreme annulus and/or left ventricle dilation, the valve geometry features required for MitraClip implantation, in particular the coaptation length ≥2 mm and the coaptation depth <11 mm, could be missing. We report the case of a 43-year-old patient with severe ischemic mitral regurgitation and lack of leaflet coaptation mainly due to posterior mitral leaflet retraction, showing step by step the possible pharmacological and mechanical methods to modify the mitral valve apparatus allowing the leaflet grasping using MitraClip device.

Keywords

Mitral Regurgitation Systolic Pulmonary Artery Pressure Functional Mitral Regurgitation Functional NYHA Class Leaflet Coaptation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Video 12.1

(MOV 1256 kb)

Video 12.2

(MOV 1412 kb)

Video 12.3

(MOV 2779 kb)

References

  1. 1.
    Franzen O, van der Heyden J, Baldus S, et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13(5):569–76.CrossRefPubMedGoogle Scholar
  2. 2.
    Neuss M, Schau T, Schoepp M, et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail. 2012;5:786–95.CrossRefGoogle Scholar
  3. 3.
    Adamo M, Barbanti M, Curello S, et al. Effectiveness of MitraClip therapy in patients with refractory heart failure. J Interv Cardiol. 2015;28(1):61–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol. 2009;54:686–94.CrossRefPubMedGoogle Scholar
  5. 5.
    Feldman T, Foster E, Glower DD, for the EVEREST II Investigators, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.CrossRefPubMedGoogle Scholar
  6. 6.
    Attizzani GF, Ohno Y, Capodanno D, et al. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. JACC Cardiovasc Interv. 2015;8(1 Pt A):74–82.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Marianna Adamo
    • 1
  • Claudia Fiorina
    • 1
  • Salvatore Curello
    • 1
  • Ermanna Chiari
    • 1
  • Giuliano Chizzola
    • 1
  • Elena Pezzotti
    • 1
  • Rosa Mastropierro
    • 1
  • Federica Ettori
    • 1
    Email author
  1. 1.Cardiothoracic DepartmentSpedali CiviliBresciaItaly

Personalised recommendations